This white paper provides an overview on botulinum toxins, including their mechanism, their clinical use, their regulation in the United States, and best practices for conducting clinical trials for these products. This paper can serve as both a great introduction to the topic and as a general refresher for those already familiar with botulinum toxin.

Back to Resource Center

Impactful expertise and true partnership. Give your trial the Symbio touch.